|
BE615511A
(enExample)
|
1961-03-25 |
|
|
|
|
NL292958A
(enExample)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
WO1998021951A1
(en)
|
1996-11-18 |
1998-05-28 |
Emisphere Technologies, Inc. |
Methods and compositions for inducing oral tolerance in mammals
|
|
CA2298824A1
(en)
|
1997-08-06 |
1999-02-18 |
Smithkline Beecham Corporation |
Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
*
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
DK1106614T3
(da)
|
1999-12-10 |
2004-04-13 |
Pfizer |
5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
|
|
ATE548031T1
(de)
|
2000-12-18 |
2012-03-15 |
Inst Med Molecular Design Inc |
Inhibitoren gegen die produktion und freisetzung entzündungfördernder zytokine
|
|
JP4485806B2
(ja)
|
2002-03-20 |
2010-06-23 |
ユニヴァーシティ オブ メリーランド，ボルチモア |
神経系細胞の非選択的陽イオンチャネルおよび脳腫脹を治療する方法
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
AU2003242131A1
(en)
|
2002-06-05 |
2003-12-22 |
Institute Of Medicinal Molecular Design, Inc. |
Immunity-related protein kinase inhibitors
|
|
EA009523B1
(ru)
|
2002-06-05 |
2008-02-28 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Ингибиторы в отношении активации ар-1 и nfat
|
|
AU2003242137A1
(en)
|
2002-06-05 |
2003-12-22 |
Institute Of Medicinal Molecular Design, Inc |
Medicament for treatment of diabetes
|
|
KR101054562B1
(ko)
|
2002-06-06 |
2011-08-04 |
가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 |
항알레르기약
|
|
EA009051B1
(ru)
*
|
2002-06-06 |
2007-10-26 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
О-замещенные гидроксиарильные производные
|
|
EP1535610A4
(en)
|
2002-06-10 |
2008-12-31 |
Inst Med Molecular Design Inc |
THERAPEUTIC CANCER
|
|
AU2003242098B2
(en)
|
2002-06-10 |
2008-11-20 |
Institute Of Medicinal Molecular Design, Inc |
Inhibitors against activation of NFkappaB
|
|
WO2003103657A1
(ja)
*
|
2002-06-11 |
2003-12-18 |
株式会社医薬分子設計研究所 |
神経変性疾患治療剤
|
|
KR20050029209A
(ko)
|
2002-07-15 |
2005-03-24 |
미리어드 제네틱스, 인크. |
화합물, 조성물 및 이의 사용방법
|
|
DK1590458T3
(da)
|
2003-02-06 |
2013-02-04 |
Univ Belfast |
Bradykinin B2-receptorantagonistpeptid fra amfibiehud
|
|
BRPI0409867A
(pt)
|
2003-05-01 |
2006-05-16 |
Innogene Kalbiotech Pte Ltd |
composição farmacêutica contendo lactato e usos da mesma
|
|
EP1649852A1
(en)
|
2003-07-16 |
2006-04-26 |
Institute of Medicinal Molecular Design, Inc. |
Chromatosis remedies
|
|
WO2005035514A2
(en)
|
2003-10-08 |
2005-04-21 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
US20070254956A1
(en)
|
2003-10-29 |
2007-11-01 |
Koichi Shudo |
Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation
|
|
US7378509B2
(en)
|
2003-12-02 |
2008-05-27 |
Anesiva, Inc. |
NF-kappaB oligonucleotide decoy molecules
|
|
DE602005024704D1
(de)
|
2004-09-18 |
2010-12-23 |
Univ Maryland |
Therapeutische mittel zum targeting des nc ca-atp-kanals und verwendungsverfahren dafür
|
|
ATE486606T1
(de)
|
2004-09-18 |
2010-11-15 |
Univ Maryland |
Therapeutische mittel zum targeting des ncca-atp- kanals und verwendungsverfahren dafür
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
CN101132791A
(zh)
|
2005-01-04 |
2008-02-27 |
诺瓦提斯公司 |
用于鉴定替加色罗在慢性便秘患者中的功效的生物标记
|
|
TWI462745B
(zh)
*
|
2005-04-28 |
2014-12-01 |
Takeda Pharmaceutical |
安定的乳化組成物
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
*
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
MX2008015532A
(es)
|
2006-06-06 |
2008-12-18 |
Genentech Inc |
Composiciones y metodos para la modulacion del desarrollo vascular.
|
|
US7803377B2
(en)
|
2006-06-06 |
2010-09-28 |
Genentech, Inc. |
Anti-DLL4 antibodies and methods using same
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
US20100056444A1
(en)
|
2006-10-12 |
2010-03-04 |
Sven Martin Jacobson |
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
US7906555B2
(en)
|
2006-10-26 |
2011-03-15 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
US9316633B2
(en)
*
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
WO2008067373A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
US20080214486A1
(en)
|
2006-11-28 |
2008-09-04 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
EP2111224B1
(en)
|
2007-01-12 |
2016-07-13 |
University of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
WO2008089212A1
(en)
|
2007-01-16 |
2008-07-24 |
Ipintl, Llc |
Novel composition for treating metabolic syndrome
|
|
US20120183600A1
(en)
*
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
CA2618099C
(en)
|
2007-02-09 |
2016-09-20 |
University Of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
CN105123670B
(zh)
|
2007-02-17 |
2018-12-14 |
哈佛学院董事会 |
用于进行组织保存的组合物以及方法
|
|
WO2008133884A2
(en)
|
2007-04-23 |
2008-11-06 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
US8557867B2
(en)
|
2007-06-22 |
2013-10-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Inhibitors of NCCa-ATP channels for therapy
|
|
JP2010532385A
(ja)
|
2007-07-02 |
2010-10-07 |
ユ，ミン |
複合的癌治療の方法、組成物および標的
|
|
JP5470046B2
(ja)
*
|
2007-10-23 |
2014-04-16 |
株式会社医薬分子設計研究所 |
Ｐａｉ−１産生抑制剤
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
PL2868315T3
(pl)
|
2007-12-04 |
2018-06-29 |
Biogen Chesapeake Llc |
Udoskonalone preparaty i sposoby liofilizacji oraz uzyskiwane liofilizaty
|
|
GB0724340D0
(en)
*
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
AU2008345225A1
(en)
*
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US20110034560A1
(en)
|
2008-01-29 |
2011-02-10 |
Sven Jacobson |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
*
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
WO2009139925A1
(en)
|
2008-05-16 |
2009-11-19 |
Panacea Pharmaceuticals, Inc. |
Methods for the treatment of brain edema
|
|
EP2719380A3
(en)
|
2008-09-16 |
2014-07-30 |
University of Maryland, Baltimore |
SUR1 inhibitors for therapy
|
|
US20120010178A1
(en)
|
2008-10-21 |
2012-01-12 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
CA2749575C
(en)
|
2009-01-12 |
2016-05-03 |
Versitech Limited |
Compounds and uses thereof for treating inflammation and modulating immune responses
|
|
US20120039805A1
(en)
|
2009-02-20 |
2012-02-16 |
Pangea Biosciences, Inc. |
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
|
|
CN102883742B
(zh)
|
2010-03-10 |
2014-09-24 |
佛罗里达大学研究基金会有限公司 |
用松弛素调节水孔蛋白
|
|
KR20230165363A
(ko)
|
2010-07-19 |
2023-12-05 |
바이오젠 체사피크 엘엘씨 |
글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
|
|
EP2598145A1
(en)
*
|
2010-07-28 |
2013-06-05 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition for treatment of respiratory and inflammatory diseases
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
WO2012125749A2
(en)
|
2011-03-14 |
2012-09-20 |
Io Therapeutics, Inc. |
INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
|
|
EP2717883B1
(en)
|
2011-05-02 |
2017-03-22 |
Stichting VUmc |
Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (arg)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
*
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
WO2013165606A1
(en)
|
2012-05-04 |
2013-11-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
JP6238969B2
(ja)
|
2012-05-08 |
2017-11-29 |
エアロミクス・インコーポレイテッドＡｅｒｏｍｉｃｓ，Ｉｎｃ． |
新規方法
|
|
WO2015037659A1
(ja)
|
2013-09-13 |
2015-03-19 |
株式会社医薬分子設計研究所 |
水溶液製剤及びその製造方法
|
|
WO2015069948A1
(en)
|
2013-11-06 |
2015-05-14 |
Aeromics, Llc |
Novel methods
|
|
GEP20207082B
(en)
|
2013-12-13 |
2020-04-10 |
Vertex Pharma |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
EP3218354A4
(en)
|
2014-11-13 |
2018-06-13 |
Aeromics, Inc. |
Novel methods
|
|
US10900040B2
(en)
|
2015-05-29 |
2021-01-26 |
University Of Maryland, Baltimore |
Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells
|
|
EP3359162B1
(en)
|
2015-10-07 |
2022-12-21 |
Biogen Chesapeake LLC |
Methods of treating injuries or conditions related to cns edema
|
|
WO2017197371A1
(en)
|
2016-05-13 |
2017-11-16 |
Aeromics, Inc. |
Crystals
|
|
WO2018023035A1
(en)
|
2016-07-29 |
2018-02-01 |
Biogen Chesapeake Llc |
Methods of medical treatment with sur1-trpm4 channel inhibitors
|
|
IL300341A
(en)
*
|
2020-08-05 |
2023-04-01 |
Jiangsu Simcere Pharm Co Ltd |
A pharmaceutical composition of an aquaporin inhibitor and a method for its preparation
|